Fungi · Scientific monograph
Tremella fuciformis
Snow Fungus / Silver Ear Mushroom
For educational and scientific research only. Not medical advice. Independently verify claims against the cited primary sources. Consult a qualified healthcare professional before using any plant or fungal preparation.
Research areas: Neurological & Cognitive Research, Dermatological Research, Immunological Research
Research overview
Historical use
Used in Traditional Chinese Medicine and as a prized culinary delicacy for over 2,000 years. Known in China as 'Bai Mu Er' (white wood ear). Historically associated with female beauty and longevity — legend holds that Yang Guifei, the Tang Dynasty imperial consort famed for her beauty, used it daily. Used medicinally for lung conditions, dry cough, and as a yin tonic.
Modern research context
Tremella polysaccharide (TP) is studied for neuroprotective effects (NGF-like activity), skin hydration, and immunomodulation via multiple molecular mechanisms [1]. The high water-retention capacity of TP — comparable to hyaluronic acid — underpins its extensive use in cosmetic dermatology [2]. A clinical trial demonstrated improvements in glycated haemoglobin (HbA1c) and waist circumference in overweight subjects following T. fuciformis supplementation [3]. Anti-proliferative activity against EBV-associated gastric cancer has been documented via ferroptosis induction [4]. Anti-inflammatory properties relevant to atopic dermatitis are under preclinical investigation [5].
Adverse effects
Very well tolerated. Rare allergic reactions. No significant adverse effects documented in available clinical literature.
Contraindications
No absolute contraindications established. Caution with immunosuppressants due to immunostimulant properties.
Clinical and phytochemical data
Used part
Fruiting body
Primary active compounds
Tremella polysaccharide (TP) — acidic heteropolysaccharide
Glucuronoxylomannans
Ergosterol
Trehalose
Phenolic compounds
Mechanism of action
Tremella polysaccharides stimulate NGF secretion in astrocytes (similar mechanism to Lion's Mane), promoting neuronal differentiation and survival. Anti-inflammatory effects via inhibition of NF-κB and COX-2. Skin-hydrating effects attributed to polysaccharide hygroscopic properties and upregulation of hyaluronic acid synthase (HAS2). Immunomodulation via TLR-4 activation.
Pharmacokinetics
Absorption
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Oral bioavailability of TP is low due to high molecular weight. Some fractions absorbed in the GI tract; bioactive effects also mediated at mucosal level. Human PK data very limited.
Distribution
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — High-molecular-weight polysaccharides remain largely confined to the GI tract and GALT; smaller oligosaccharide fragments may enter systemic circulation via lymphatic uptake. Skin distribution is suggested by clinical hydration data, consistent with promotion of dermal hyaluronic acid synthesis. No formal human PK distribution studies.
Metabolism
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Partially fermented by gut microbiota to SCFAs. Absorbed fractions undergo hepatic metabolism.
Excretion
No human pharmacokinetic data are available for this species. The following is derived from preclinical animal studies and in vitro data only, and may not reflect human pharmacology. — Primarily fecal; renal for absorbed small molecular weight fragments.
Safety and interactions
Drug interactions
Lack of clinical studies prevents interaction grading. Unknown safety profile with concomitant drug use.
Toxicity
LD50 >10 g/kg (oral, mice). No organ toxicity in preclinical studies. Human clinical data very limited but no safety signals identified.
Special precautions
Pregnancy
Insufficient human clinical data. Dietary consumption likely safe; concentrated supplements — avoid due to lack of evidence.
Lactation
No data on breast milk excretion. Dietary use likely acceptable; supplements — insufficient data.
Hepatic impairment
No hepatotoxicity documented. Standard precautions apply.
Renal impairment
No specific risk identified. No dose adjustment data.
Sources and references
- [1] - Yang D., "Tremella polysaccharide: The molecular mechanisms of its drug action.", Prog Mol Biol Transl Sci, 2019, PMID: 31030755
- [2] - Mineroff J., "The potential cutaneous benefits of Tremella fuciformis.", Arch Dermatol Res, 2023, PMID: 36757441
- [3] - Gitsomboon S., "Tremella fuciformis beverage improves glycated hemoglobin A1c and waist circumference in overweight Thai adults: a double-blind, randomized, placebo-controlled study.", BMC Nutr, 2024, PMID: 38439104
- [4] - Kong W., "Tremella fuciformis polysaccharides induce ferroptosis in Epstein-Barr virus-associated gastric cancer.", Aging (Albany NY), 2024, PMID: 38244583
- [5] - Xie L., "Tremella fuciformis polysaccharides alleviate induced atopic dermatitis in mice by regulating the Th1/Th2 balance.", Front Pharmacol, 2022, PMID: 36091780